Oryzon Genomics announced the appointment of Mr. Antonio Fornieles, Ms. Isabel Aguilera and Mr. Ramon Adell as independent directors to the company's Board of Directors, effective November 3, 2015. The addition of three independent directors, approved by shareholders, strengthens the board of Oryzon, as the company prepares to go public on the Spanish Continuous Market in Madrid. Mr. Antonio Fornieles, Ms. Isabel Aguilera and Mr. Ramon Adell have substantial expertise and will be valuable contributors to Oryzon's mission and anticipated needs.

Mr. Antonio Fornieles will act as Lead Director, Ms. Isabel Aguilera will act as Chairman of the Remuneration and Nomination Committee, and Mr. Ramon Adell will be chairing the Audit and Compliance Committee. Mr. Antonio Fornieles brings to Oryzon over 30 years of audit experience. Mr. Fornieles has been Second Vice Chairman at Abengoa SA since January 2015 and also serves as its lead director.

Previously as Global Chief Operating Officer at KPMG. Ms. Isabel Aguilerais is currently a Non-Executive Director and adviser to various companies, such as Indra, Banco BMN, AEGON Spain and EGASA. Mr. Ramon Adell serves as Professor of Financial Economics and Accounting at the University of Barcelona.